Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

TELESTA THERAPEUTICS INC > This story will be fixed soon .... $$$$$$$$
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(46)
•••
Comment by DryBoneson Apr 03, 2016 6:15pm
348 Views
Post# 24725879

RE:RE:RE:RE:This story will be fixed soon .... $$$$$$$$

RE:RE:RE:RE:This story will be fixed soon .... $$$$$$$$Talk about stale dated.  That story is long over. Most of us read it long ago.  Where is the new story, the one that will get some activity going at TST headquarters instead of the bumscratching?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities